Effect of Shenqi Compound Formula on PPARγ in White Adipose Tissue of Rats with Macrovascular Lesion in Early Stage of Diabetes
Objective: To investigate the effect of Shenqi Compound Formula (SCF) on peroxisome proliferators- activated receptor γ (PPARγ) in white adipose tissue of rats with macrovascular lesion in early stage of diabetes. Methods: Corresponding treatment was given to rats in model group, Ramipril group, nor...
Saved in:
Published in | Journal of traditional Chinese medicine Vol. 28; no. 2; pp. 134 - 138 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
West China Hospital of Sichuan University,Chengdu 610041,China%Chengdu University of Traditional Chinese Medicine,China%Food and Drug Administration of Henan,China
01.06.2008
|
Subjects | |
Online Access | Get full text |
ISSN | 0255-2922 |
DOI | 10.1016/S0254-6272(08)60032-1 |
Cover
Summary: | Objective: To investigate the effect of Shenqi Compound Formula (SCF) on peroxisome proliferators- activated receptor γ (PPARγ) in white adipose tissue of rats with macrovascular lesion in early stage of diabetes. Methods: Corresponding treatment was given to rats in model group, Ramipril group, normal control group, low dosage SCF group and high dosage SCF group respectively for 32 days. The expressions of PPARγ and adiponectin Messenger RNA (mRNA) were detected by real-time reverse transcriptase poly- merase chain reaction. Results: The expressions of PPARγ and adiponectin mRNA increased significantly in both low and high dosage SCF groups as compared with the model group, and a positive linear correlation was found between the expressions of PPARγ and adiponectin mRNA. Conclusions: SCF can prevent macrovascular lesion in early stage of diabetes, which is possibly related with up-regulating expressions of PPARγ and activating PPARγ. |
---|---|
Bibliography: | Peroxisome proliferators-activated receptor γ (PPARγ) Shenqi Compound Formula; TypeⅡ Diabetes; Macrovascular lesion; Peroxisome proliferators-activated receptor γ (PPARγ) 11-2167/R R28 TypeⅡ Diabetes Shenqi Compound Formula Macrovascular lesion |
ISSN: | 0255-2922 |
DOI: | 10.1016/S0254-6272(08)60032-1 |